Literature DB >> 10204576

Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex?

W R Tyor1, L D Middaugh.   

Abstract

Although psychoactive drugs are commonly used by AIDS patients, it is unclear whether commonly abused drugs, such as cocaine and ethanol, affect the course of HIV-associated dementia (HADC). Epidemiological studies have resulted in conflicting conclusions as to what role, if any, abused drugs play in HADC. In this review we discuss the clinical and pathological evidence that cocaine and ethanol might exacerbate the detrimental effects of HIV infection on the brain. We also review studies of cocaine and ethanol effects on various components of the immune system both in the presence and absence of retroviral infection. Data from these studies indicate that cocaine and ethanol have profound effects on the immune system that, in many respects, are enhanced by retroviral infection. We conclude that abused drugs likely affect the course of HADC but that proof awaits an examination of their interactive effects in an appropriate in vivo system of retroviral encephalitis.

Entities:  

Mesh:

Year:  1999        PMID: 10204576     DOI: 10.1002/jlb.65.4.475

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  20 in total

Review 1.  Mechanisms of the blood-brain barrier disruption in HIV-1 infection.

Authors:  Michal Toborek; Yong Woo Lee; Govinder Flora; Hong Pu; Ibolya E András; Edward Wylegala; Bernhard Hennig; Avindra Nath
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 2.  Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.

Authors:  Suman Jayadev; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-17       Impact factor: 4.147

3.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

Review 4.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

5.  SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation.

Authors:  Michael Weed; Robert J Adams; Robert D Hienz; Kelly A Meulendyke; Michael E Linde; Janice E Clements; Joseph L Mankowski; M Christine Zink
Journal:  J Neuroimmune Pharmacol       Date:  2011-05-28       Impact factor: 4.147

6.  Chronic cocaine exposure in the SCID mouse model of HIV encephalitis.

Authors:  W C Griffin; L D Middaugh; W R Tyor
Journal:  Brain Res       Date:  2006-12-26       Impact factor: 3.252

7.  HIV-associated neurocognitive disorders: Five new things.

Authors:  Jeffrey A Rumbaugh; William Tyor
Journal:  Neurol Clin Pract       Date:  2015-06

8.  Human immunodeficiency virus type 1 gp120 and ethanol coexposure in rat organotypic brain slice cultures: Curtailment of gp120-induced neurotoxicity and neurotoxic mediators by moderate but not high ethanol concentrations.

Authors:  A Belmadani; E J Neafsey; M A Collins
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

9.  Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-D-aspartate glutamate receptors to produce persisting spatial learning deficits.

Authors:  R L Self; K J Smith; T R Butler; J R Pauly; M A Prendergast
Journal:  Neuroscience       Date:  2009-07-18       Impact factor: 3.590

10.  Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia.

Authors:  Navneet K Dhillon; Rachel Williams; Fuwang Peng; Yi-Jou Tsai; Sukhbir Dhillon; Brandon Nicolay; Milind Gadgil; Anil Kumar; Shilpa J Buch
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.